Escherichia coli resistance to major antibiotics is increasing in almost all countries in Europe. E. coli causes urinary tract and more serious infections and is one of the most common bacteria causing infections.
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union Conference and ECDC , HIV experts from across the European Union discussed how to reverse the HIV epidemic and how to prepare Europe to achieve the set target of ending AIDS by 2030.
The global rise of carbapenemase-producing Enterobacteriaceae (CPE) is alarming and is an increasing threat to patient safety, in Europe and globally.
EU case definition for diarrhoea and haemolytic uremic syndrome (HUS) caused by the epidemic strain Shiga toxin 2-producing Escherichia Coli (STEC) O104:H4
Public health advice on prevention of diarrhoeal illness with special focus on Shiga toxin - producing Escherichia coli (STEC), also called verotoxin - producing E. coli (VTEC) or enterohaemorrhagic E. coli (EHEC)
Outbreak of Shiga toxin - producing Escherichia coli (STEC), also called verotoxin-producing E. coli (VTEC) or enterohaemorrhagic E. coli (EHEC) in 2011
The XXVIII IUSTI (International Union Against Sexually Transmitted Infections) Europe Congress addressed the broad range of science and clinical practice in the field of sexually transmitted infections and HIV.
Haemophilus influenzae type b (Hib) is an obligate human pathogen and an important cause of invasive bacterial infections in both children and adults, with the highest incidence among young children.
In 2010, ECDC published the guidance HIV testing: increasing uptake and effectiveness in the European Union. In consideration of the recent developments in this field, ECDC is considering to update the guidance in 2016.